Aqua Bio Technology ASA to present at Nordic Health Care Conference 2011

Aqua Bio Technology ASA (ABT) a company that develops, produces and markets patented ingredients and technologies to the international cosmetic and skin care industry, will be presenting at the Nordic Health Care Conference in Oslo on the 6^th December 2011. The Conference will take place at DNB Markets, Oslo.

The presentation will be held by CEO Arvid Lindberg and will focus on the progress of the commercialization of ABT's lead ingredient Aquabeautine XL®.

Afterwards, the presentation will be made available on ABT ASA's website www.aquabiotechnology.com.

About ABT
Aqua Bio Technology ASA (ABT) develops, produces and markets patented ingredients and technologies to the international cosmetic and skin care industry.
ABT's lead ingredient Aquabeautine XL® is a patented marine solution that adds moisture and improves the renewal of skin cells in an effective and gentle manner. It is also proven to deliver anti-aging effects in vivo. Aquabeautine XL® is derived from the hatching fluid of salmon, and contains patented proteins such as the enzyme Zonase(TM).

For further information please contact:

Arvid Lindberg, CEO, Aqua Bio Technology ASA
Telephone: +47 98 24 54 10; E-mail: arvid@aquabiotech.no

 

 

This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.